← ANALYSTS · TIPRANKS
Jenna Davidner · Barclays
Hits
25%
4 of 16 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
−5.3%
Over a year after the rating, TipRanks’ measure
Our companies rated now
5
Buy / hold / sell: 4 / 1 / 0
Upside of the analyst’s targets
+55.1%
Average over 5 current targets, to the last price
The market’s answer to the ratings
−1.2%
Day-0 move against SPY in the rating’s direction, average over 3 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 15on TipRanks 05:07 | COLLIWMCollegium Pharmaceutical · $733M | Reiterated | Buy | $48.00 | +107.0% | +2.7%next day +1.1% | ↗ |
| Oct 9on TipRanks Oct 12 05:07 | TARSIWMTarsus Pharmaceuticals · $3.5B | Reiterated | Buy | $110 | +61.6% | +0.7%next day +1.8% · 5 days −5.0% | ↗ |
| Oct 6on TipRanks 04:50 | XERSIWMXeris Pharmaceuticals · $1.8B | Reiterated | Buy | $12.00 → $14.00+16.7% | +35.8% | −1.1%next day +0.6% · 5 days +1.4% | ↗ |
| Sep 16on TipRanks Sep 17 03:50 | TARSIWMTarsus Pharmaceuticals · $3.5B | Initiated | Buy | $110 | +61.6% | −0.3%next day +0.7% · 5 days −6.4% | ↗ |
| Aug 20on TipRanks 03:55 | XERSIWMXeris Pharmaceuticals · $1.8B | Reiterated | Buy | $12.00 | +16.4% | −1.2%next day +0.8% · 5 days −1.1% | ↗ |
| Aug 18on TipRanks Aug 19 03:11 | COLLIWMCollegium Pharmaceutical · $733M | Reiterated | Buy | $56.00 → $48.00−14.3% | +107.0% | +2.2%next day +0.6% · 5 days −3.4% | ↗ |
| Aug 17on TipRanks 04:55 | PHATIWMPhathom Pharmaceuticals · $607M | Reiterated | Buy | $14.00 | +102.3% | −2.7%next day +0.4% · 5 days −5.5% | ↗ |
| Aug 17on TipRanks 04:55 | PCRXIWMPacira Pharmaceuticals · $1.4B | Reiterated | Hold | $25.00 | −31.2% | +1.5%next day +3.9% · 5 days +8.2% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗